OGN Organon & Co.
$13.89 -0.14%
US Stock · Health Care
RSI (14) · 30 / 70 bands
MACD (12, 26, 9)
Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Point at or drag across the chart to read a day. EOD data.
1D
-0.14%
YTD
+93.70%
P/E
17.13
P/B
2.48
ROE
22.1%
Div yield
9.9%
Beta
0.54
Market cap
$3.6B
RSI (14)
61
Next earnings
Feb 10, 2027
Same sector · Health Care
Compare OGN with NVO and JNJ →Follow OGN in the AlfaCat app
Watchlist, price and earnings alerts, the chart offline. Free, no account, no ads.
The economy behind it · United States
Economy this week on BullDozer →GDP, % on year
2.1
Q3 2026
Inflation, %
3.7
Sep 2026
Unemployment, %
3.9
Oct 2026
10-yr yield, %
5.13
Oct 2026
From BullDozer, our sister site for country statistics (open sources: OECD, IMF, Eurostat, ILO). Full United States profile →
Previous session
close of Nov 20, 2026 · EOD, no live order bookOpen
$13.89
Close
$13.89
Day high
$13.91
Day low
$13.89
Volume
3.6M
Latest headlines
Organon Presents New Analysis of Pooled Post-Hoc Phase 3 Data on VTAMA® (tapinarof) cream, 1%, Demonstrating Consistent Efficacy in Atopic Dermatitis Across Diverse Patient Subgroups at ACAAI
Yahoo Finance · Nov 12
Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know
Yahoo Finance · Nov 10
New Real-World Evidence Presented by Organon at the American College of Rheumatology (ACR) Annual Meeting Evaluated a Large-Scale Switch to HADLIMA® (adalimumab-bwwd) Across United States Veterans Affairs Healthcare System
Yahoo Finance · Nov 7
Organon to Present New Analysis on VTAMA® (tapinarof) cream, 1% at the 2026 American College of Allergy, Asthma & Immunology Annual Scientific Meeting
Yahoo Finance · Nov 5
Organon (OGN) Q3 Results Highlight A Thin Margin Cushion
Yahoo Finance · Nov 1
Organon (OGN) Q3 Earnings and Revenues Top Estimates
Yahoo Finance · Oct 30
Headlines via Yahoo Finance · links open the source · not an endorsement.
Recent SEC filings
8-K Oct 30, 2026 View → 10-Q Oct 30, 2026 View → 8-K Jul 31, 2026 View → 10-Q Jul 31, 2026 View → 8-K Jul 23, 2026 View →
Source: SEC EDGAR · opens the official filing.
Research & reports
External resources — availability and opinions are theirs, not ours.
This is reference data for your own analysis — not a recommendation to buy or sell OGN. Try it in the Lab to size a position and see the risk.